Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice
Objective: To model Parkinsonian-pyramidal syndrome (PARK15) in mice and investigate the impact of loss of F-box only protein 7 (FBXO7) in neurons on proteasomal activity.…Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening
Objective: To evaluate the incidence of depressive symptoms in Parkinsonian patients in a large cohort followed at a tertiary movement disorders center. Background: Despite relative…Hyposmia as a predictor of non-motor symptom in patients with de novo Parkinson’s disease
Objective: To evaluate hyposmia as a predictor of non-motor features in patients with early Parkinson's disease (PD). Background: Hyposmia is quite a common finding in…The heterogeneity of fatigue in different stages of Parkinson’s disease
Objective: To identify factors associated with fatigue in different stages of PD. Background: Fatigue is an important contributor to poor quality of life. However, it…P100 latency of pattern reversal visual evoked potential and visual hallucination in Parkinson’s disease
Objective: To investigate whether P100 latency of pattern reversal visual evoked potential (PR-VEP) can predict the development of visual hallucination (VH) in Parkinson's disease (PD).…Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease
Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) and to determine clinical and biological variables that predict new onset EDS in the cohort…Frequency of non-motor symptoms in Iranian patients with Parkinson’s disease
Objective: To evaluate prevalence of nanometer symptoms in patients with Parkinson's disease. Background: While PD (Parkinson's disease) is diagnosed on the basis of motor symptoms,…Movement disorders (Parkinson’s disease) in Uzbekistan: Epidemiologic, clinical and therapeutic aspects
Objective: The aim was to determine the epidemiologic, clinical and therapeutic aspects of patients treated for PD. Methods: This was a prospective and cross-sectional study…Prevalence of Parkinson’s disease in the region of Coquimbo, Chile
Objective: To determine the rate of prevalence of PD in the region of Coquimbo, Chile. Background: Parkinson's disease is a common neurodegenerative disease, second after…Non-contact boxing in Parkinson’s disease
Objective: To narratively review the effectiveness of non-contact boxing and explore its feasibility in individuals with Parkinson's disease (PD). Background: Complementary therapies have shown outcomes…
- « Previous Page
- 1
- …
- 385
- 386
- 387
- 388
- 389
- …
- 425
- Next Page »